Fulminant Demyelination & Autoimmune Encephalitis

Recognize an Inflammatory Emergency

The outline names fulminant demyelinating disease and autoimmune encephalitis separately from ordinary toxic-metabolic coma. Severe inflammatory disease can produce extensive edema, acute myelopathy, brainstem dysfunction, respiratory weakness, or refractory seizures. Stabilize airway, ventilation, circulation, and seizures while evaluating the cause. An immune hypothesis should not delay empirical treatment of a plausible serious infection or urgent exclusion of spinal compression.

Ask how quickly the syndrome evolved and which systems are affected. Multifocal neurologic deficits with encephalopathy suggest a different process from a single abrupt vascular-territory deficit. A spinal sensory level, sphincter dysfunction, and evolving weakness suggest cord disease. However, the tempo overlaps across infection, vascular disease, neoplasm, and inflammation; no single feature proves an immune cause.

Fulminant Demyelinating Syndromes

Acute disseminated encephalomyelitis (ADEM) typically combines encephalopathy with multifocal neurologic dysfunction and inflammatory demyelinating lesions. It is more common in children but can occur in adults. Severe hemorrhagic variants can progress rapidly with edema and mass effect. Assess brain and spinal imaging and seek infection or other mimics when the clinical course is atypical.

Severe multiple sclerosis, aquaporin-4-IgG-associated neuromyelitis optica spectrum disorder, and MOG antibody-associated disease can present with major optic, brainstem, or spinal deficits. These labels are not interchangeable. Longitudinally extensive cord lesions, area postrema symptoms, optic-nerve patterns, and antibody results can help distinguish them, but lesion length alone is not a complete diagnosis.

In acute myelopathy, MRI must assess compression, hemorrhage, infarction, infection, and inflammation. An apparently central neurologic weakness can also coexist with respiratory muscle failure or autonomic dysfunction. Monitor bulbar function, respiratory mechanics when feasible, bladder status, and cardiovascular stability. Do not wait for severe blood-gas abnormalities when clinical respiratory reserve is declining.

Investigation and Treatment Reasoning

High-dose corticosteroids are commonly used for severe inflammatory demyelination, with plasma exchange considered for severe or insufficiently responsive attacks and other therapies selected by syndrome and response. These are specialist decisions with infection, glucose, bleeding, and hemodynamic risks. The fact that corticosteroids are harmful for traumatic cerebral edema does not make them inappropriate for a separate inflammatory indication.

Autoimmune Encephalitis

Autoimmune encephalitis may present with subacute memory change, altered mental state, psychiatric symptoms, seizures, movement abnormalities, sleep disturbance, dysautonomia, or hypoventilation. Anti-NMDAR disease can produce prominent dyskinesias and autonomic instability. LGI1-associated disease may include faciobrachial dystonic seizures and hyponatremia. Other syndromes have different tumor associations and treatment responses.

MRI can be normal initially. CSF inflammation can be modest or absent, and antibody panels are neither perfectly sensitive nor perfectly specific. Interpret a positive result in the phenotype and specimen context; low-specificity isolated serum findings can mislead. Send paired or targeted serum and CSF testing when appropriate and assess for an associated neoplasm according to the syndrome, age, and clinical findings.

When infectious encephalitis remains plausible, begin appropriate empirical antimicrobials while testing proceeds. An early negative HSV PCR may require repeat sampling if suspicion remains. Once the immune diagnosis is sufficiently supported and important alternatives are addressed, expert recommendations support prompt first-line immunotherapy, commonly corticosteroids, IVIG, or plasma exchange. Escalation such as rituximab depends on response and the presumed immune mechanism; it is not a mandatory identical sequence for every antibody.

ICU Complications and Recovery

Manage seizures, aspiration risk, infection, dysautonomia, immobility, nutrition, and medication effects. Abnormal movements are not automatically seizures; correlate with EEG and bedside findings. Antipsychotic sensitivity, QT effects, and sedative accumulation may complicate care. Recovery can be slow even after the acute inflammatory process is treated, so distinguish prolonged recovery from evidence of irreversible injury.

In a vignette with psychiatric change followed by seizures, dyskinesias, autonomic instability, and hypoventilation, recognize an encephalitic syndrome and investigate immune and infectious causes. A normal initial MRI does not justify dismissing the condition as primary psychiatric disease. In a separate rapidly progressive myelopathy, the immediate priority is to exclude compression and assess respiratory and autonomic risks before choosing a disease-specific immune treatment.

Sources checked October 17, 2026: autoimmune encephalitis acute-management recommendations and 2024 Canadian consensus. Recommendations include expert consensus where trial evidence is limited.